PowerUp Acquisition Corp. shareholders approve extension of business combination deadline to Feb 2025

Aspire Biopharma Holdings, Inc.

Shareholders approved extending the deadline to consummate an initial business combination from May 23, 2024 to February 17, 2025.
Shareholders also approved removing the requirement that the company have at least $5,000,001 in net tangible assets before closing a deal.
A total of 1,226,085 Class A ordinary shares were redeemed for cash in connection with the meeting.
Both proposals passed with overwhelming support: Extension 7,753,807 for / 62,254 against; NTA removal 7,816,061 for / 0 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.